- Pfizer Globally Licenses ChemAxon's Platform For Markush Structure
Searching And Enumeration
ChemAxon - a leading provider of cheminformatics software for the life
sciences industry has entered into agreement with Pfizer to provide its
Markush searching and structure enumeration functionality for global
development and deployment within Pfizer's global R&D facilities.
"Markush structure search and enumeration is becoming of critical
importance for structure IP and patent development." said Alex Drijver, CEO
of ChemAxon. "It is an area where ChemAxon has developed a high area of
expertise and where we are moving very much into the forefront."